Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Discover general insights on medical cannabis, including benefits, usage tips, research updates, and expert advice for safe and effective treatment.
Jim Shannon, MP for Strangford, led Thursday’s Westminster Hall debate, highlighting critical issues in the medical cannabis industry, with the most apparent being the masses of patients that could benefit from these treatments, yet struggle to access them.
Cancer affects the lives of millions of people around the world and everyone’s story is different. As a clinic offering personalised medical cannabis treatment, Releaf is embracing the theme for World Cancer Day on Tuesday 4 February and advocating for patients to be front and centre of their care.
365 days ago, on the 1st of February 2024 Releaf medical cannabis clinic officially launched. Ever since then, lives have been changed on a daily basis - and our patient stories attest to this. To celebrate this milestone, and change many more lives, we’re reducing the price of our initial consultations by £60 - offering appointments with specialist GMC registered clinicians for just £39.99. Simply use the code 1YEAR60 at checkout.
When we discuss the 'strength' (or potency) of a given medical cannabis cultivar, it is easy to fall into the trap of simply looking at the THC levels. This is only one part of the picture - but a crucial one, nonetheless.
Neuropathic pain is a common type of pain that is caused by damage to the nervous system. It can be linked to various sources, including disease and injury; however, sufficient treatment can often be difficult to achieve. As medical cannabis becomes more widely available, a growing number of patients may wonder whether it could be an effective alternative or add-on therapy to conventional treatments for neuropathic pain.
From the very start of cannabis stigmatisation and prohibition, hemp was unfairly lumped into the same category as 'marijuana,' 'weed,' or even the evocative 'ganja,’
Last week, we launched our brand new, built-from-the-ground-up Releaf Patient Portal. We have invested over £2 million into this bespoke piece of tech, and it's been a long time in the making.
In December 2024, Releaf’s website attracted 9510 daily visits and nearly 1,000 page views an hour. In this blog we break down the data, and evaluate why thousands trust our reliable content about medical cannabis in the UK.
Medical cannabis has been legal in the UK since 2018, but there is still a lot of confusion and misinformation out there around its regulation and the rights of medical cannabis patients.
As we progress into the New Year, thousands of people around the country (and the world) are embracing lifestyle changes, from cutting back on their alcohol intake for Dry January to setting targets for improving their mental health.
Almost a year after launching, the Cannabis Industry Council’s ‘Yes We Can’ research report was published, revealing what UK based medical cannabis patients think about various aspects of the medical cannabis industry. Here, we take a look at what they found, and, what this could mean.
The Food Standards Agency (FSA)— the body responsible for the regulation of consumer CBD products in the UK—has hinted at ambitious new targets for CBD products in the UK market, which could see a push for zero detectable THC levels.
While surgical complications are statistically rare, the period of recovery can be fraught with its own challenges.
January is Glaucoma Awareness Month - a time to raise awareness and support for those living with glaucoma, the world’s leading cause of blindness.
At Releaf, one of our core commitments is to provide accurate, reliable and relevant information about medical cannabis treatments here in the UK, and in order to do this we’ve conducted our own research on numerous occasions.
Cannabis-based medicinal products (CBMPs) are now prescribed in a variety of forms in the UK. But one product type you won’t find in the formulary is cannabis resin.
The hectic festive season is finally drawing to a close, which can only mean one thing: hundreds of thousands of people across the country will be taking part in Dry January.
Why don’t we let patients choose their cannabis medicine from a menu? It’s a question that new patients sometimes ask, and it’s worth unpacking.
At Releaf, our mission is to enhance the quality of life of individuals across the UK by giving them back control of their health. And throughout 2024, as well as providing patient-focused care and unwavering support through our expert clinical and patient support teams, we’ve had the privilege of speaking with our patients one on one to find out more about their health journeys.Â
Explore the potential of medical cannabis in 2025 as an alternative healthcare option in the UK. Learn how Releaf helps patients address health concerns like anxiety, chronic pain, and more with personalised, patient-centred treatment plans. Discover the benefits, conditions eligible for treatment, and how to take the first step toward a healthier you this New Year.
While most people look for alternative treatment options because conventional medicines haven’t met their needs, an increase in prescription drug shortages in the UK is leaving more patients without access to effective medications.
Growing awareness and acceptance of cannabis-based products has been on the rise in recent years. In addition to a flourishing CBD consumer market, medical cannabis has become increasingly accessible to patients with a variety of health concerns.
This year, we’ve taken a leaf from Spotify’s book and put together a collection of our favourite moments during 2024. As the year draws to a close, here we reflect on our milestones, growth, and most importantly, the transformative difference we’re making for patients.
If you’re new to medical cannabis treatment, it’s natural to have concerns about its safety, particularly regarding its potential psychoactive effects.
